Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 38


Variation in breast cancer subtypes with age and race/ethnicity.

Parise CA, Bauer KR, Caggiano V.

Crit Rev Oncol Hematol. 2010 Oct;76(1):44-52. doi: 10.1016/j.critrevonc.2009.09.002. Epub 2009 Oct 2.


Risk factors for triple-negative breast cancer in women under the age of 45 years.

Dolle JM, Daling JR, White E, Brinton LA, Doody DR, Porter PL, Malone KE.

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1157-66. doi: 10.1158/1055-9965.EPI-08-1005. Epub 2009 Mar 31.


A case-control study of oral contraceptive use and incident breast cancer.

Rosenberg L, Zhang Y, Coogan PF, Strom BL, Palmer JR.

Am J Epidemiol. 2009 Feb 15;169(4):473-9. doi: 10.1093/aje/kwn360. Epub 2008 Dec 13.


A prospective study of body size and breast cancer in black women.

Palmer JR, Adams-Campbell LL, Boggs DA, Wise LA, Rosenberg L.

Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1795-802.


Oral, injected and implanted contraceptives and breast cancer risk among U.S. Hispanic and non-Hispanic white women.

Sweeney C, Giuliano AR, Baumgartner KB, Byers T, Herrick JS, Edwards SL, Slattery ML.

Int J Cancer. 2007 Dec 1;121(11):2517-23.


Epidemiology of basal-like breast cancer.

Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, Smith LV, Labbok MH, Geradts J, Bensen JT, Jackson S, Nyante S, Livasy C, Carey L, Earp HS, Perou CM.

Breast Cancer Res Treat. 2008 May;109(1):123-39. Epub 2007 Jun 20. Erratum in: Breast Cancer Res Treat. 2008 May;109(1):141. Dressler, Lynn G [added].


Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.

Shantakumar S, Terry MB, Paykin A, Teitelbaum SL, Britton JA, Moorman PG, Kritchevsky SB, Neugut AI, Gammon MD.

Am J Epidemiol. 2007 May 15;165(10):1187-98. Epub 2007 Mar 3.


Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers.

Gupta PB, Proia D, Cingoz O, Weremowicz J, Naber SP, Weinberg RA, Kuperwasser C.

Cancer Res. 2007 Mar 1;67(5):2062-71.


Ethnicity and breast cancer: factors influencing differences in incidence and outcome.

Chlebowski RT, Chen Z, Anderson GL, Rohan T, Aragaki A, Lane D, Dolan NC, Paskett ED, McTiernan A, Hubbell FA, Adams-Campbell LL, Prentice R.

J Natl Cancer Inst. 2005 Mar 16;97(6):439-48.


Comparative analysis of breast cancer risk factors among African-American women and White women.

Hall IJ, Moorman PG, Millikan RC, Newman B.

Am J Epidemiol. 2005 Jan 1;161(1):40-51.


Etiology of hormone receptor-defined breast cancer: a systematic review of the literature.

Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME.

Cancer Epidemiol Biomarkers Prev. 2004 Oct;13(10):1558-68. Review.


Risk factors for breast cancer according to estrogen and progesterone receptor status.

Colditz GA, Rosner BA, Chen WY, Holmes MD, Hankinson SE.

J Natl Cancer Inst. 2004 Feb 4;96(3):218-28.


Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status.

McCredie MR, Dite GS, Southey MC, Venter DJ, Giles GG, Hopper JL.

Br J Cancer. 2003 Nov 3;89(9):1661-3.


Hormonal factors and the risk of breast cancer according to estrogen- and progesterone-receptor subgroup.

Cotterchio M, Kreiger N, Theis B, Sloan M, Bahl S.

Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):1053-60.


Clinical practice. Combination estrogen-progestin oral contraceptives.

Petitti DB.

N Engl J Med. 2003 Oct 9;349(15):1443-50. Review. No abstract available. Erratum in: N Engl J Med. 2004 Jan 1;350(1):92.


Breast cancers among very young premenopausal women (United States).

Althuis MD, Brogan DD, Coates RJ, Daling JR, Gammon MD, Malone KE, Schoenberg JB, Brinton LA.

Cancer Causes Control. 2003 Mar;14(2):151-60.


Use of oral contraceptives and breast cancer risk: The Norwegian-Swedish Women's Lifestyle and Health Cohort Study.

Kumle M, Weiderpass E, Braaten T, Persson I, Adami HO, Lund E.

Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1375-81.


Oral contraceptives and the risk of breast cancer.

Marchbanks PA, McDonald JA, Wilson HG, Folger SG, Mandel MG, Daling JR, Bernstein L, Malone KE, Ursin G, Strom BL, Norman SA, Wingo PA, Burkman RT, Berlin JA, Simon MS, Spirtas R, Weiss LK.

N Engl J Med. 2002 Jun 27;346(26):2025-32.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk